来源: MarketWatch ↗

Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals

|

暂时无法翻译，请重试。

来源报道重点

Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.

在 MarketWatch 阅读原始报道 ↗

推荐市场

此报道未识别到特定资产；可浏览实时 USDT 参考交易对。

浏览市场 →

USDC/USDT

$1.0000

-0.02%

BTC/USDT

$86,907.76

+7.13%

ETH/USDT

$2,780.45

+5.52%

SOL/USDT

$118.72

+7.60%

XRP/USDT

$1.53

+8.60%